candesartan has been researched along with Pemphigus in 2 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
Pemphigus: Group of chronic blistering diseases characterized histologically by ACANTHOLYSIS and blister formation within the EPIDERMIS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Saito, Y | 1 |
Hayashi, S | 1 |
Yamauchi, A | 1 |
Okamoto, M | 1 |
Kaminaga, T | 1 |
Hamasaki, Y | 1 |
Hatamochi, A | 1 |
Igawa, K | 1 |
Bae, YI | 1 |
Yun, SJ | 1 |
Lee, SC | 1 |
Park, GT | 1 |
Lee, JB | 1 |
1 review available for candesartan and Pemphigus
Article | Year |
---|---|
Tracing the origins of active amide group-positive drug-induced pemphigus vulgaris along the Silk Road: a case report of candesartan-induced pemphigus vulgaris and review of nonthiol drug-induced pemphigus.
Topics: Aged; Amides; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Humans; Male; Pemphigus; | 2018 |
1 other study available for candesartan and Pemphigus
Article | Year |
---|---|
Pemphigus foliaceus induced by an angiotensin II receptor blocker.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Biphenyl Compounds; Female | 2008 |